You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CCR4

Showing 1 - 25 of 1,758
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma, Relapse, Refractory Trial in Chapel Hill (Chemotherapy, Cell infusion)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 13, 2023

Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,

Recruiting
  • Mycosis Fungoides
  • +2 more
  • Extracorporeal Photopheresis
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital
Jun 15, 2022

Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

Active, not recruiting
  • Folliculotropic Mycosis Fungoides
  • +7 more
  • Extracorporeal Photopheresis
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

HIV Trial in Cincinnati (SB-728-T, Expanded unmodified autologous CD4+ T cells)

Active, not recruiting
  • HIV Infections
  • SB-728-T
  • Expanded unmodified autologous CD4+ T cells
  • Cincinnati, Ohio
    University of Cincinnati
Jan 1, 2022

Hiv Trial in Philadelphia (CD4 CAR+CCR5 ZFN T-cells)

Active, not recruiting
  • Hiv
  • CD4 CAR+CCR5 ZFN T-cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 6, 2022

HPV Infection, HPV Vaccination Trial in Thika (Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine)

Recruiting
  • HPV Infection
  • HPV Vaccination
  • Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
  • Thika, Kiambu, Kenya
    Phrd-Ccr-Kemri
Jun 22, 2022

Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

Recruiting
  • Recurrent Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 18, 2022

Recurrent DLBCL, Recurrent High Grade B-Cell Lymphoma, Recurrent Transformed B-Cell Non-Hodgkin Lymphoma Trial in United States

Active, not recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +5 more
  • Mogamulizumab
  • Pembrolizumab
  • Sacramento, California
  • +7 more
Sep 15, 2022

Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States

Recruiting
  • Mycosis Fungoides
  • +11 more
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +12 more
Jan 7, 2023

HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

Recruiting
  • HIV Infection
  • +10 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • La Jolla, California
  • +3 more
Dec 7, 2022

Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma Trial in Stanford (KW-0761)

Completed
Has Results
  • Peripheral T-cell Lymphoma
  • Cutaneous T-cell Lymphoma
  • KW-0761
  • Stanford, California
    Stanford University
Dec 3, 2020

Peripheral T-Cell Lymphoma Trial in United States (KW-0761)

Completed
Has Results
  • Peripheral T-Cell Lymphoma
  • KW-0761
  • Los Angeles, California
  • +4 more
Dec 3, 2020

Hand Eczema Trial in Worldwide (Ruxolitinib cream, Vehicle)

Withdrawn
  • Hand Eczema
  • Phoenix, Arizona
  • +48 more
Nov 14, 2022

Migraine Trial in Worldwide (Atogepant, Placebo for Atogepant, Topiramate)

Not yet recruiting
  • Migraine
  • Innsbruck, Tirol, Austria
  • +84 more
Feb 20, 2023

Gastric Cancer, Esophageal Cancer, Lung Cancer Trial in Suita (Mogamulizumab, Nivolumab)

Completed
  • Gastric Cancer
  • +4 more
  • Mogamulizumab
  • Nivolumab
  • Suita, Osaka, Japan
    Osaka University
Mar 4, 2020

HIV Trial in Los Angeles, San Diego, Torrance (Maraviroc)

Completed
Has Results
  • HIV Infections
  • Los Angeles, California
  • +2 more
Aug 6, 2020

Spondylitis, Ankylosing Trial in Worldwide (CC-99677, Placebo)

Active, not recruiting
  • Spondylitis, Ankylosing
  • Flagstaff, Arizona
  • +139 more
Dec 9, 2022

Cutaneous T-Cell Lymphoma Trial in Worldwide (KW-0761, Vorinostat)

Completed
Has Results
  • Cutaneous T-Cell Lymphoma
  • Birmingham, Alabama
  • +72 more
Jul 22, 2022

Episodic Migraine Trial in Worldwide (Atogepant 60 mg, Placebo)

Completed
  • Episodic Migraine
  • Atogepant 60 mg
  • Placebo
  • Colton, California
  • +113 more
Aug 12, 2022

Psoriatic Arthritis Trial in Worldwide (PF-06700841, Placebo)

Completed
Has Results
  • Psoriatic Arthritis
  • Maroochydore, Queensland, Australia
  • +47 more
Aug 2, 2021

Episodic Migraine, Chronic Migraine Trial in Worldwide (Atogepant 60 mg)

Enrolling by invitation
  • Episodic Migraine
  • Chronic Migraine
  • Atogepant 60 mg
  • Phoenix, Arizona
  • +126 more
May 4, 2022

Spondyloarthritis Trial in Worldwide (Golimumab, Placebo)

Completed
  • Spondyloarthritis
  • Golimumab
  • Placebo
  • Brno, Czechia
  • +70 more
Jan 12, 2022

Atopic Dermatitis Trial in Netherlands, United States (RPT193, Placebo)

Completed
  • Atopic Dermatitis
  • Anniston, Alabama
  • +13 more
Sep 28, 2021

Lymphoma Trial in Canada (bortezomib, gemcitabine HCl)

Completed
  • Lymphoma
  • Edmonton, Alberta, Canada
  • +10 more
Apr 6, 2020

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Terminated
Has Results
  • Rheumatoid Arthritis (RA)
  • Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
  • +29 more
Aug 18, 2021